Asthma drug, Xolair, introduced as prefilled syringe
The asthma treatment which has not been able to pass the wall of the health insurance since its approval in 2007, Xolair(generic name: omalizumab), was introduced as a prefilled syringe type.
According to the Ministry of Food and Drug Safety, Novartis Korea acquired domestic commercialization ap...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
